Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model

Infection and Immunity

Volumn 74, Issue 9, 2006, Pages 5200-5210

  Fisher, Derek J ^a   Fernandez Miyakawa, Mariano E ^b   Sayeed, Sameera ^a   Poon, Rachael ^c   Adams, Victoria ^c   Rood, Julian I ^c   Uzal, Francisco A ^b   McClane, Bruce A ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; BACTERIAL TOXIN; BACTERIAL VACCINE; BACTERIN; CLOSTRIDIUM BETA2 TOXIN; CLOSTRIDIUM PERFRINGENS TOXIN; CLOSTRIDIUM TOXIN; ENTEROTOXIN; TOXOID; UNCLASSIFIED DRUG; VACCINE;

ANAEROBIC BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM PERFRINGENS TYPE C; CONTROLLED STUDY; CPB GENE; CPB2 GENE; CPE GENE; DOMESTIC ANIMAL; EXPERIMENTAL MOUSE; IMMUNE RESPONSE; IMMUNOASSAY; INTESTINE INFECTION; LETHALITY; MOUSE; NECROTIZING ENTERITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PFOA GENE; PLC GENE; PRIORITY JOURNAL; SERODIAGNOSIS; SUPERNATANT; TOXEMIA; TOXIN ANALYSIS; VACCINATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; BASE SEQUENCE; BLOTTING, WESTERN; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; DEATH; DISEASE MODELS, ANIMAL; GENES, BACTERIAL; GENOTYPE; INJECTIONS, INTRAVENOUS; MICE; MOLECULAR SEQUENCE DATA;

EID: 33748075477     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00534-06     Document Type: Article

References (42)

1. Awad, M. M., D. M. Ellemor, R. L. Boyd, J. J. Emmins, and J. I. Rood. 2001. Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene. Infect. Immun. 69:7904-7910.
2. Ba-Thein, W., M. Lyristis, K. Ohtani, I. T. Nisbet, H. Hayashi, J. I. Rood, and T. Shimizu. 1996. The virR/virS locus regulates the transcription of genes encoding extracellular toxin production in Clostridium perfringens. J. Bacteriol. 178:2514-2520.
3. Brace, R. D. 1985. An up-and-down procedure for acute toxicity testing. Fundam. Appl. Toxicol. 5:151-157.
4. Bueschel, D. M., B. H. Jost, S. J. Billington, H. T. Trinh, and J. G. Songer. 2003. Prevalence of cpb2, encoding beta2 toxin, in Clostridium perfringens field isolates: correlation of genotype with phenotype. Vet. Microbiol. 94:121-129.
5. Cheung, J. K., and J. I. Rood. 2000. The VirR response regulator from Clostridium perfringens binds independently to two imperfect direct repeats located upstream of the pfoA promoter. J. Bacteriol. 182:57-66.
6. Collie, R. E., J. F. Kokai-Kun, and B. A. McClane. 1998. Phenotypic characterization of enterotoxigenic Clostridium perfringens isolates from non-foodborne human gastrointestinal diseases. Anaerobe 4:69-79.
7. Czeczulin, J. R., R. E. Collie, and B. A. McClane. 1996. Regulated expression of Clostridium perfringens enterotoxin in naturally cpe-negative type A, B, and C isolates of C. perfringens. Infect. Immun. 64:3301-3309.
8. Fisher, D. J., K. Miyamoto, B. Harrison, S. Akimoto, M. R. Sarker, and B. A. McClane. 2005. Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene. Mol. Microbiol. 56:747-762.
9. Garmory, H. S., N. Chanter, N. P. French, D. Bueschel, J. G. Songer, and R, W. Titball. 2000. Occurrence of Clostridium perfringens beta2-toxin amongst animals, determined using genotyping and subtyping PCR assays. Epidemiol. Infect. 124:61-67.
10. Gui, L., C. Subramony, J. Fratkin, and M. D. Hughson. 2002. Fatal enteritis necroticans (pigbel) in a diabetic adult. Mod. Pathol. 15:66-70.
11. Hall, T. A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
12. Knight, P. A., J. Queminet, J. H. Blanchard, and J. H. Tilleray. 1990. In vitro tests for the measurement of clostridial toxins, toxoids and antisera. II. Titration of Clostridium perfringens toxins and antitoxins in cell culture. Biologicals 18:263-270.
13. Labbe, R. G., and D. K. Key. 1979. Raffinose increases sporulation and enterotoxin production by Clostridium perfringens type A. Appl. Environ. Microbiol. 37:1196-1200.
14. Lawrence, G., and R. Cooke. 1980. Experimental pigbel: the production and pathology of necrotizing enteritis due to Clostridium welchii type C in the guinea-pig. Br. J. Exp. Pathol 61:261-271.
15. Lawrence, G. W. 1997. The pathogenesis of enteritis necroticans, p. 197-210. In J. I. Rood, B. A. McClane, J. G. Songer, and R. W. Titball (ed.), The clostridia: molecular biology and pathogenesis. Academic Press, San Diego, CA.
16. Lawrence, G. W., D. Lehmann, G. Anian, C. A. Oakley, G. Saleu, M. J. Barker, and M. W. Davis. 1990. Impact of active immunisation against enteritis necroticans in Papua New Guinea. Lancet 336:1165-1167.
17. Lawrence, G. W., T. G. Murrell, and P. D. Walker. 1979. Pigbel. P. N. G. Med. J. 22:1-2.
18. Li, D. Y., A. O. Scheimann, J. G. Songer, R. E. Person, M. Horwitz, L. Resar, and K. B. Schwarz. 2004. Enteritis necroticans with recurrent enterocutaneous fistulae caused by Clostridium perfringens in a child with cyclic neutropenia. J. Pediatr. Gastroenterol. Nutr. 38:213-215.
19. Lucken, R., A. Daas, and M. E. Behr-Gross. 2002. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines. Dev. Biol. (Basel) 111:171-180.
20. McClane, B. A., A. P. Wnek, K. I. Hulkower, and P. C. Hanna. 1988. Divalent cation involvement in the action of Clostridium perfringens type A enterotoxin. Early events in enterotoxin action are divalent cation-independent. J. Biol. Chem. 263:2423-2435.
21. Ohtani, K., H. I. Kawsar, K. Okumura, H. Hayashi, and T. Shimizu. 2003. The VirR/VirS regulatory cascade affects transcription of plasmid-encoded putative virulence genes in Clostridium perfringens strain 13. FEMS Microbiol. Lett. 222:137-141.
22. Papua New Guinea Institute of Medical Research. 26 May 2003, posting date. Enteric diseases. [Online.] Papua New Guinea Institute of Medical Research. http://www.pngimr.org.pg/enteric_diseases.html.
23. Petrillo, T. M., C. M. Beck-Sague, J. G. Songer, C. Abramowsky, J. D. Fortenberry, L. Meacham, A. G. Dean, H. Lee, D. M. Bueschel, and S. R. Nesheim. 2000. Enteritis necroticans (pigbel) in a diabetic child. N. Engl. J. Med. 342:1250-1253.
24. Radostits, O. M., C. C. Gay, D. C. Blood, and K. W. Hinchcliff. 2000. Veterinary medicine: a textbook of the diseases of cattle, sheep, pigs, goats, and horses, 9th ed. W.B. Saunders Company Ltd., London, United Kingdom.
25. Rood, J. I. Virulence genes of Clostridium perfringens. Annu. Rev. Microbiol. 52:333-360.
26. Sakurai, J., and C. L. Duncan. 1979. Effect of carbohydrates and control of culture pH on beta toxin production by Clostridium perfringens type C. Microbiol. Immunol. 23:313-318.
27. Sakurai, J., and Y. Fujii. 1987. Purification and characterization of Clostridium perfringens beta toxin. Toxicon 25:1301-1310.
28. Sayeed, S., M. E. Fernandez-Miyakawa, D. J. Fisher, V. Adams, R. Poon, J. I. Rood, F. A. Uzal, and B. A. McClane. 2005. Epsilon-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model. Infect. Immun. 73:7413-7421.
29. Severin, W. P., A. A. de la Fuente, and M. F. Stringer. 1984. Clostridium perfringens type C causing necrotising enteritis. J. Clin. Pathol. 37:942-944.
30. Shimizu, T., K. Ohtani, H. Hirakawa, K. Ohshima, A. Yamashita, T. Shiba, N. Ogasawara, M. Hattori, S. Kuhara, and H. Hayashi. 2002. Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc. Natl. Acad. Sci. USA 99:996-1001,
31. Shimizu, T., H. Yaguchi, K. Ohtani, S. Banu, and H. Hayashi. 2002. Clostridial VirR/VirS regulon involves a regulatory RNA molecule for expression of toxins. Mol. Microbiol. 43:257-265.
32. Sloan, J., T. A. Warner, P. T. Scott, T. L. Bannam, D. I. Berryman, and J. I. Rood. 1992. Construction of a sequenced Clostridium perfringens- Escherichia coli shuttle plasmid. Plasmid 27:207-219.
33. Smedley, J. G., 3rd, D. J. Fisher, S. Sayeed, G. Chakrabarti, and B. A. McClane. 2004. The enteric toxins of Clostridium perfringens. Rev. Physiol. Biochem. Pharmacol. 152:183-204.
34. Songer, J. G. 1996. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 9:216-234.
35. Springer, S., and H. J. Selbitz. 1999. The control of necrotic enteritis in sucking piglets by means of a Clostridium perfringens toxoid vaccine. FEMS Immunol. Med. Microbiol. 24:333-336.
36. Stevens, D. L., J. Mitten, and C. Henry. 1987. Effects of alpha and theta toxins from Clostridium perfringens on human polymorphonuclear leukocytes. J. Infect. Dis. 156:324-333.
37. Tonnellier, M., E. Maury, J. Guglielminotti, and G. Offenstadt. 2001. A fatal Sandwich. Lancet Infect. Dis. 1:202.
38. U.S. Department of Agriculture. 2005, posting date. Veterinary biological products, June 2005, licenses and permittees. [Online.] U.S. Department of Agriculture, Washington, DC. http://www.aphis.usda.gov/vs/cvb/RegsGuidance /ProdCodeBookJune2005.pdf.
39. Uzal, F. A., and W. R. Kelly. 1997. Effects of the intravenous administration of Clostridium perfringens type D epsilon toxin on young goats and lambs. J. Comp. Pathol. 116:63-71.
40. Walker, P. D., W. H. Foster, P. A. Knight, D. S. Freestone, and G. Lawrence. 1979. Development, preparation and safety testing of a Clostridium welchii type C toxoid. I. Preliminary observations in man in Papua New Guinea. J. Biol. Stand. 7:315-323.
41. Wen, Q., K. Miyamoto, and B. A. McClane. 2003. Development of a duplex PCR genotyping assay for distinguishing Clostridium perfringens type A isolates carrying chromosomal enterotoxin (cpe) genes from those carrying plasmid-borne enterotoxin (cpe) genes. J. Clin. Microbiol. 41:1494-1498.
42. Wnek, A. P., R. J. Strouse, and B. A. McClane. 1985. Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin. Infect. Immun. 50:442-448.